HMOX1 and chronic myelogenous leukemia, BCR-ABL1 positive: We have recently shown that Hsp32 (HO-1) is expressed in leukemic cells in Ph+ chronic myeloid leukemia (CML) and that Hsp32-targeting drugs produce growth arrest and apoptosis in leukemic cells [28,29].